BDBM267781 4-(4-amino-1-{(3R)-1-[(3-methyloxetan-3-yl)carbonyl]piperidin-3-yl}-1H-pyrazolo[4,3-c]pyridin-3-yl)-N-(4-ethylpyridin-2-yl)benzamide::US9718828, Example, 387

SMILES Cc1ccnc(NC(=O)c2ccc(cc2)-c2nn([C@@H]3CCCN(C3)C(=O)C3(C)COC3)c3ccnc(N)c23)c1

InChI Key InChIKey=LRHYBFOGGWKQLD-OAQYLSRUSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 267781   

TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267781(4-(4-amino-1-{(3R)-1-[(3-methyloxetan-3-yl)carbony...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent